Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)

NCT05451043 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer
Hepatocellular Cancer
Biliary Tract Cancer
Cholangiocarcinoma

Interventions

BIOLOGICAL: Durvalumab
DRUG: Gemcitabine
DRUG: Nab paclitaxel
BIOLOGICAL: Tremelimumab
DRUG: Propranolol
DRUG: Cisplatin

Sponsor

AHS Cancer Control Alberta